Total Funding
48
48
Total FundingPost-IPO Debt raised
Growth Score 48 in past quarter
-9 pts
Heat Score 48 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
84553
Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging.
- ANIRVAN GHOSH: Chief Executive Officer
- DAN MARQUESS: Chief Scientific Officer
About the Company
Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.
